Back to search results

Postpartum Lifestyle Intervention in WIC Clinics

This study, called STRIVE, is looking at the best ways to help new mothers who have obesity or a history of gestational diabetes (diabetes during pregnancy) make healthy lifestyle changes. We are comparing two approaches to delivering a program called Group Lifestyle Balance (GLB) in WIC clinics. One approach uses 24 in-person health coaching sessions over a year. The other uses 12 in-person sessions with extra support from technology, like tools for tracking your progress. We want to see which approach is better at helping women make these changes and lose weight. You might be able to join if you are a woman aged 18 or older, gave birth in the last 6 weeks to 12 months, and have obesity (BMI of 30 or higher) or a history of gestational diabetes. The study is currently unclear on its recruitment status.

Study design
This study is an interventional trial comparing two different ways to deliver a lifestyle program. It plans to enroll 722 participants across 38 WIC clinics.
What's involved
You would participate in either 24 in-person health coaching sessions or 12 in-person sessions with technology support over one year.
Compensation
Not stated in the trial record.
Follow-up
Your weight reduction will be measured at 3, 6, 9, and 12 months. There will also be a follow-up visit 6 months after the 12-month intervention ends.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06116149

Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics

Recruiting
NAAges 18+InterventionalPrevention
Tulane University
~722 participants
Updated 2025-07-25 on ClinicalTrials.gov
What's tested:In-person health coach delivery of the GLBTechnology-assisted health coach delivery of the GLB

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Difference in uptake (primary implementation outcome)
Measured over Measured from baseline to 12 months
+1 more outcome measured

Conditions

Obesity
Gestational Diabetes
Lifestyle, Healthy
Glucose Intolerance During Pregnancy
PreDiabetes
Hyperglycemia

Explore related trials

Gestational DiabetesObesityPrediabetes

Where it's being run

1 sites across 1 states
Louisiana1

Who to contact

Tara Dobson, BA
[email protected]
504.988.9922
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Serve a large number of WIC postpartum participants
Willing and able to provide space for the study
Age 18 or older
Gave birth in the past 6 weeks to 12 months
Obesity or history of gestational diabetes mellitus (Current BMI ≥30 kg/m², OR Medical-record documented history of gestational diabetes mellitus and BMI ≥25 kg/m²)
No self-reported diabetes (other than gestational diabetes)
Hemoglobin A1c \<6.5%
Not currently pregnant or planning to become pregnant in the next 6 months
No plans to move outside of the study region in the next 12 months
Access to a smartphone
Willing and able to participate in the intervention and provide consent
Not an immediate family member of the staff at the WIC clinic
Other concerns regarding ability to meet trial requirements, at the discretion of the principal investigator or study coordinator

What this trial measures

  • Difference in uptake (primary implementation outcome)Measured from baseline to 12 months

    The primary implementation outcome will be the difference between study arms in a composite uptake score, as defined by a composite score consisting of the percent of sessions attended and the percentage of times in which participants record weight, activity, and diet compared to what is recommended by the intervention.

  • Difference in mean 12-month weight reduction (primary health-related outcome)Measured at 3, 6, 9 and 12 months

    The primary health-related outcome will be difference in mean weight reduction from baseline to 12 months between study arms